iBio, Inc.IBIONYSE
Loading
Year-over-year operating income growth rate
Percentile
P23
Within normal range
vs 2Y Ago
-1.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -16.70% |
| Q3 2025 | -14.49% |
| Q2 2025 | -6.54% |
| Q1 2025 | -10.41% |
| Q4 2024 | -7.62% |
| Q3 2024 | -20.45% |
| Q2 2024 | 5.98% |
| Q1 2024 | 19.35% |
| Q4 2023 | 11.89% |
| Q3 2023 | -2.78% |
| Q2 2023 | 19.52% |
| Q1 2023 | 41.65% |
| Q4 2022 | -38.46% |
| Q3 2022 | 54.81% |
| Q2 2022 | -148.91% |
| Q1 2022 | 6.13% |
| Q4 2021 | -38.39% |
| Q3 2021 | 44.64% |
| Q2 2021 | -31.04% |
| Q1 2021 | 4.53% |
| Q4 2020 | -8.97% |
| Q3 2020 | -136.39% |
| Q2 2020 | 27.93% |
| Q1 2020 | -28.81% |
| Q4 2019 | 18.16% |
| Q3 2019 | 4.89% |
| Q2 2019 | -7.51% |
| Q1 2019 | 6.10% |
| Q4 2018 | -1.65% |
| Q3 2018 | -0.10% |
| Q2 2018 | -12.97% |
| Q1 2018 | -1.93% |
| Q4 2017 | -1.96% |
| Q3 2017 | 12.90% |
| Q2 2017 | 1.96% |
| Q1 2017 | -18.38% |
| Q4 2016 | -5.42% |
| Q3 2016 | -14.52% |
| Q2 2016 | 10.35% |
| Q1 2016 | -36.29% |